Peter von Doersten
President chez Montana Neuroscience Institute Foundation
Profil
Peter von Doersten is the founder of Sinapis Pharma, Inc. which was founded in 2009.
He is currently the President & Director of Montana Neuroscience Institute Foundation.
Postes actifs de Peter von Doersten
| Sociétés | Poste | Début |
|---|---|---|
Montana Neuroscience Institute Foundation
 Montana Neuroscience Institute Foundation Miscellaneous Commercial ServicesCommercial Services Montana Neuroscience Institute Foundation operates as a non-profit organization. It conducts research and provides education on neurological diseases and the neurosciences. The company is headquartered in Missoula, MT. | President | - |
Anciens postes connus de Peter von Doersten
| Sociétés | Poste | Fin |
|---|---|---|
Sinapis Pharma, Inc.
 Sinapis Pharma, Inc. BiotechnologyHealth Technology Sinapis Pharma, Inc. provides biotechnology services. It develops methamphetamine, a low-dose intravenous infusion. The company was founded by Howard C. Chandler and Peter Von Doersten in 2009 and is headquartered in Jacksonville, FL. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Sinapis Pharma, Inc.
Sinapis Pharma, Inc. BiotechnologyHealth Technology Sinapis Pharma, Inc. provides biotechnology services. It develops methamphetamine, a low-dose intravenous infusion. The company was founded by Howard C. Chandler and Peter Von Doersten in 2009 and is headquartered in Jacksonville, FL. | Health Technology |
Montana Neuroscience Institute Foundation
Montana Neuroscience Institute Foundation Miscellaneous Commercial ServicesCommercial Services Montana Neuroscience Institute Foundation operates as a non-profit organization. It conducts research and provides education on neurological diseases and the neurosciences. The company is headquartered in Missoula, MT. | Commercial Services |
